Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12612460 | Anti-PD-1 antibodies and fusion proteins | 🖼🧊📄§ | 2026-04-28 | 2044-12-20 | 0 | 31 |
| 12612424 | HPK1 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-07-03 | 0 | 31 |
| 12612389 | Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2040-07-14 | 0 | 31 |
| 12612407 | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist | 🖼🧊📄§ | 2026-04-28 | 2040-02-06 | 0 | 31 |
| 12612408 | Pyrazolone-fused pyrimidine compound, preparation method for same and applications thereof | 🖼🧊📄§ | 2026-04-28 | 2040-06-28 | 0 | 31 |
| 12611456 | Use of thiazole amide compounds for modulating human immune response | 🖼🧊📄§ | 2026-04-28 | 2040-09-16 | 0 | 31 |
| 12611460 | Eyedrop compositions | 🖼🧊📄§ | 2026-04-28 | 2039-09-18 | 0 | 31 |
| 12611379 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-13 | 0 | 31 |
| 12611381 | Cationic hyaluronic acid coated spanlastics and preparation and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-02 | 0 | 31 |
| 12611400 | Solid lipid nano-composition containing berberine and cinnamonaldehyde effective in treating diabetes, dyslipidemia, and method of preparing the same | 🖼🧊📄§ | 2026-04-28 | 2040-12-04 | 0 | 31 |
| 12611428 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611443 | Methods and compositions related to therapeutic peptides for cancer therapy | 🖼🧊📄§ | 2026-04-28 | 2041-06-14 | 0 | 31 |
| 12611374 | Dermatological collar for non-human animals | 🖼🧊📄§ | 2026-04-28 | 2042-03-09 | 0 | 31 |
| 12611429 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2042-08-03 | 0 | 31 |
| 12611385 | Use of two-dimensional nanomaterial in inhibition of coronavirus | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12612343 | PSMA binder and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-04-13 | 0 | 31 |
| 12611408 | Methods for treating nail brittleness, fragility, or pitting | 🖼🧊📄§ | 2026-04-28 | 2039-06-04 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611467 | APOE gene therapy | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611454 | Recombinant vaccine against COVID-19 based on a paramyxovirus viral vector | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611419 | Liposomal composition for use in a method of treating Parkinson's disease | 🖼🧊📄§ | 2026-04-28 | 2043-03-09 | 0 | 31 |
| 12611432 | Immunostimulatory bacteria for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2043-07-11 | 0 | 31 |
| 12612390 | Modulators of methyl modifying enzymes, compositions and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-28 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12612384 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | 🖼🧊📄§ | 2026-04-28 | 2042-05-04 | 0 | 31 |
| 12612358 | Resorcinol-based compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-16 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12611415 | Methods and compounds for treatment of metabolic disease | 🖼🧊📄§ | 2026-04-28 | 2040-09-21 | 0 | 31 |
| 12611405 | Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2038-03-28 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12612360 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-10-19 | 0 | 31 |
| 12612457 | Humanized antibodies against Nectin-2 and drug conjugates thereof | 🖼🧊📄§ | 2026-04-28 | 2044-08-28 | 0 | 31 |
| 12612597 | Methods for preparing therapeutically active cells using microfluidics | 🖼🧊📄§ | 2026-04-28 | 2041-09-06 | 0 | 31 |
| 12612438 | Bistable type II opsins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-09-19 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12612444 | T cell receptors targeting mutations in RNA splicing factors | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12612631 | Small RNA medicament for prevention and treatment of inflammation-related diseases and combination thereof | 🖼🧊📄§ | 2026-04-28 | 2038-12-25 | 0 | 31 |
| 12610970 | Compositions for gut health | 🖼🧊📄§ | 2026-04-28 | 2040-08-14 | 0 | 31 |
| 12611401 | Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases | 🖼🧊📄§ | 2026-04-28 | 2040-05-15 | 0 | 31 |
| 12611438 | Antiviral composition comprising a nucleolin-binding peptide | 🖼🧊📄§ | 2026-04-28 | 2042-05-18 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611434 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | 🖼🧊📄§ | 2026-04-28 | 2043-06-21 | 0 | 31 |